Development of novel theragnostic radiopharmaceuticals for the imaging and treatment of the poor prognosis childhood cancer neuroblastoma.

Project: Research

Project Details

StatusFinished
Effective start/end date15/03/2021 → 14/09/2022

Collaborative partners

  • King's College London
  • Francis Crick Institute
  • UCL University College London (lead)
  • Queen Mary University of London

Funding

  • CRUK Cancer Research UK: £12,500.00